𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha

✍ Scribed by Schoch, C; Bacher, U; Hochhaus, A; Berger, U; Hiddemann, W; Hehlmann, R; Haferlach, T


Book ID
110056130
Publisher
Nature Publishing Group
Year
2004
Tongue
English
Weight
88 KB
Volume
19
Category
Article
ISSN
0887-6924

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


P107 Chromosomal abnormalities in Philad
✍ S. Jootar πŸ“‚ Article πŸ“… 2007 πŸ› Elsevier Science 🌐 English βš– 51 KB

6/155), high white cell number (13/155) (red cell unit) or low thrombocyte number (14/125) (thrombocyte unit). Summary: Donors with low hemoglobin levels have to be excluded from the blood donation service for 3 months. So, in theory haemoglobin concentration of all total blood units is suitable for

The prognosis for patients with chronic
✍ Michael W. N. Deininger; Jorge Cortes; Ron Paquette; Byung Park; Andreas Hochhau πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 380 KB

## Abstract ## BACKGROUND. Clonal cytogenetic abnormalities (CCA) were detected in Philadelphia chromosome (Ph)‐negative cells in some patients with chronic myeloid leukemia (CML) who attained a cytogenetic response to imatinib mesylate. In some patients, CCA/Ph‐negative status was associated with

Chromosomal abnormalities in Philadelphi
✍ Jorge Medina; Hagop Kantarjian; Moshe Talpaz; Susan O'Brien; Guillermo Garcia-Ma πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 107 KB

## Abstract ## BACKGROUND Anecdotal cases of chromosomal abnormalities in Philadelphia chromosome (Ph)‐negative metaphases have been reported in patients with chronic myelogenous leukemia (CML) in the chronic phase during treatment with interferon and, more recently, with imatinib. This phenomenon